期刊文献+

为急性左心衰竭患者使用磷酸肌酸钠进行治疗对其血流动力学指标及血浆NT-proBNP的影响 被引量:2

下载PDF
导出
摘要 目的:探讨为急性左心衰竭患者使用磷酸肌酸钠进行治疗对其血流动力学及血浆N末端B型利钠肽原(NT-proBNP)的影响。方法:将2017年9月至2018年9月期间任丘市人民医院收治的80例急性左心衰竭患者作为研究对象。将这些患者平均分为reference组与treatment组。对两组患者均进行吸氧、纠正电解质紊乱、利尿及强心等常规治疗。在此基础上,为treatment组患者加用磷酸肌酸钠进行治疗。然后,比较两组患者的肺毛细血管楔嵌压(PCWP)、肺动脉压(PAP)及血浆NT-proBNP的水平。结果:接受治疗后的第1 h及第6 h,treatment组患者PCWP及PAP的下降值均高于reference组患者相关指标的下降值(P<0.05)。接受治疗后的第24h及第72h,treatment组患者血浆NT-proBNP的水平均低于reference组患者(P<0.05)。结论:为急性左心衰竭患者使用磷酸肌酸钠进行治疗,可改善其血流动力学指标,降低其血浆NT-proBNP的水平。
机构地区 任丘市人民医院
出处 《当代医药论丛》 2019年第13期149-150,共2页
  • 相关文献

二级参考文献64

  • 1李瑞杰.美国心脏病学会和美国心脏协会2005成人慢性心力衰竭诊断与治疗指南(连载1)[J].临床荟萃,2006,21(11):761-764. 被引量:36
  • 2Tominaga S. A putative protein of a growth specific cDNA from BALB/e-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor[J]. FEBS Letters, 1989, 258(2): 301-304.
  • 3Sanada S, Hakuno D, Higgins LJ, et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system [J]. Journal of Clinical Investigation, 2007, 117(6): 1538-1549.
  • 4Gruson D, Lepoutre T, Ahn SA, et al. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction [J]. International Journal of Cardiology, 2014,172 (1) : 250-252.
  • 5Lupon J, de Antonio M, Vila J, et al. Development of a Novel Heart Failure Risk Tooh The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)[J]. PloS One, 2014, 9(1): 85466.
  • 6Lassus J, Gayat E, Mueller C, et al. Incremental value of hiomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study [J]. International Journal of Cardiology, 2013, 168 (3): 2186-2194.
  • 7Noveanu M, Breidthardt T, Potocki M, et al. Direct comparison of serial B-type natriuretic peptide and NT- proBNP levels for prediction of short-and long-term outcome in acute decompensated heart failure[J]. Crit Care, 2011, 15 (1): 1.
  • 8Pfister R, Schneider CA. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides [J ]. European Heart Journal, 2009, 30(3): 382-383.
  • 9Januzzi JL, Peacock WF, Maisel AS, et al. Measurement of the Interleukin Family Member ST2 in Patients With Acute DyspneaResults From the PRIDE (Pro-Brain NatriureticPeptide Investigation of Dyspnea in the Emergency Department) Study[J]. Journal of the American College of Cardiology, 2007, 50(7): 607-613.
  • 10Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction [J]. Circulation, 2004, 109(18): 2186-2190.

共引文献93

同被引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部